1-3 of 3
Kartik Anand
Close
Sort by
Journal Articles

Opportunistic Infections in Patients Receiving Daratumumab Regimens for Multiple Myeloma (MM)

Ethan A. Burns, Joe E. Ensor, Kartik Anand, Cesar Gentille, Carlo Guerrero, Ryan B. Kieser, Godsfavor Umoru, Shilpan S. Shah, Jenny H. Petkova, Siddhartha Ganguly, Lawrence Rice, Sai Ravi Kiran Pingali
Journal: Blood
Blood (2021) 138 (Supplement 1): 4740.
https://doi.org/10.1182/blood-2021-152068
Published: 2021
Journal Articles

Relationship between Poverty Rate and Survival for Diffuse Large B-Cell Lymphoma

Kartik Anand, Sai Ravi Kiran Pingali, MD, Joe Ensor, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-141700
Published: 2020
Journal Articles

Comparative Review of 30 Day Non-Relapse Mortality (NRM) in B-Cell Lymphomas Associated with Anti-CD19 Chimeric Antigen Receptor T-Cells (CAR-T) from FDA Database, Clinical Studies, and MD Anderson

Ethan Burns, MD, Kartik Anand, MD, Jason R. Westin, MD, Sai Ravi Kiran Pingali, MD, Joe Ensor, PhD, Dahlia Sano, MD, Loretta J. Nastoupil, MD MSc, Hun Ju Lee, Yago Nieto, MD PhD, Issa F. Khouri, MD, Felipe Samaniego, MD, Simrit Parmar, MBBS, Michael Wang, MD, Misha Hawkins, Sherry Adkins, ANP, Luis E. Fayad, MD, Raphael E Steiner, MD, Ranjit Nair, MBBS,MD, Sairah Ahmed, MD, Nathan H. Fowler, MD, Sattva S Neelapu, MD, Swaminathan P. Iyer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1931.
https://doi.org/10.1182/blood-2019-131077
Published: 2019